300 related articles for article (PubMed ID: 7318390)
1. The metabolism of arsenic in humans acutely intoxicated by As2O3. Its significance for the duration of BAL therapy.
Mahieu P; Buchet JP; Roels HA; Lauwerys R
Clin Toxicol; 1981 Sep; 18(9):1067-75. PubMed ID: 7318390
[TBL] [Abstract][Full Text] [Related]
2. Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning.
Heinrich-Ramm R; Schaller H; Horn J; Angerer J
Arch Toxicol; 2003 Feb; 77(2):63-8. PubMed ID: 12590357
[TBL] [Abstract][Full Text] [Related]
3. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Wang Z; Zhou J; Lu X; Gong Z; Le XC
Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
[TBL] [Abstract][Full Text] [Related]
4. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
[TBL] [Abstract][Full Text] [Related]
5. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
[TBL] [Abstract][Full Text] [Related]
6. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine.
Aposhian HV; Zheng B; Aposhian MM; Le XC; Cebrian ME; Cullen W; Zakharyan RA; Ma M; Dart RC; Cheng Z; Andrewes P; Yip L; O'Malley GF; Maiorino RM; Van Voorhies W; Healy SM; Titcomb A
Toxicol Appl Pharmacol; 2000 May; 165(1):74-83. PubMed ID: 10814555
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of arsenic after acute occupational arsine intoxication.
Apostoli P; Alessio L; Romeo L; Buchet JP; Leone R
J Toxicol Environ Health; 1997 Nov; 52(4):331-42. PubMed ID: 9354178
[TBL] [Abstract][Full Text] [Related]
8. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
Suzuki KT; Katagiri A; Sakuma Y; Ogra Y; Ohmichi M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):336-44. PubMed ID: 15276413
[TBL] [Abstract][Full Text] [Related]
9. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.
Aposhian HV; Arroyo A; Cebrian ME; del Razo LM; Hurlbut KM; Dart RC; Gonzalez-Ramirez D; Kreppel H; Speisky H; Smith A; Gonsebatt ME; Ostrosky-Wegman P; Aposhian MM
J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554
[TBL] [Abstract][Full Text] [Related]
10. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
11. Electrospray ionization tandem mass spectrometric determination of monomethylarsonic acid and dimethylarsinic acid after adduct formation with citric acid.
Minakata K; Ohnishi K; Nakamura S; Suzuki M; Suzuki O
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2624-9. PubMed ID: 19329367
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response.
Shen J; Wanibuchi H; Waalkes MP; Salim EI; Kinoshita A; Yoshida K; Endo G; Fukushima S
Toxicol Appl Pharmacol; 2006 Feb; 210(3):171-80. PubMed ID: 15950995
[TBL] [Abstract][Full Text] [Related]
13. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
[TBL] [Abstract][Full Text] [Related]
14. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.
Aposhian HV; Zakharyan RA; Avram MD; Sampayo-Reyes A; Wollenberg ML
Toxicol Appl Pharmacol; 2004 Aug; 198(3):327-35. PubMed ID: 15276412
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different medical cases in urinary arsenic speciation by fast HPLC-ICP-MS.
Heitland P; Köster HD
Int J Hyg Environ Health; 2009 Jul; 212(4):432-8. PubMed ID: 18948060
[TBL] [Abstract][Full Text] [Related]
16. Intra-individual variation in the metabolism of inorganic arsenic.
Concha G; Vogler G; Nermell B; Vahter M
Int Arch Occup Environ Health; 2002 Oct; 75(8):576-80. PubMed ID: 12373320
[TBL] [Abstract][Full Text] [Related]
17. Significance of urinary arsenic speciation in assessment of seafood ingestion as the main source of organic and inorganic arsenic in a population resident near a coastal area.
Soleo L; Lovreglio P; Iavicoli S; Antelmi A; Drago I; Basso A; Di Lorenzo L; Gilberti ME; De Palma G; Apostoli P
Chemosphere; 2008 Sep; 73(3):291-9. PubMed ID: 18657289
[TBL] [Abstract][Full Text] [Related]
18. Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic.
Soto-Reyes E; Del Razo LM; Valverde M; Rojas E
Biometals; 2005 Oct; 18(5):493-506. PubMed ID: 16333750
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors "in vitro": comparison between species and sexes.
Ferrario D; Croera C; Brustio R; Collotta A; Bowe G; Vahter M; Gribaldo L
Toxicology; 2008 Jul; 249(2-3):102-8. PubMed ID: 18524450
[TBL] [Abstract][Full Text] [Related]
20. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations.
Kligerman AD; Doerr CL; Tennant AH; Harrington-Brock K; Allen JW; Winkfield E; Poorman-Allen P; Kundu B; Funasaka K; Roop BC; Mass MJ; DeMarini DM
Environ Mol Mutagen; 2003; 42(3):192-205. PubMed ID: 14556226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
